Sophia Genetics Sa (SOPH)

$5.35 -0.24 (-4.29%)
Market Cap 448.84M
Revenue (ttm) 77.27M
Net Income (ttm) -79.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -102.24%
Debt to Equity Ratio 1.05
Volume 386,200
Avg Vol 189,720
Day's Range N/A - N/A
Shares Out 83.90M
Stochastic %K 22%
Beta 0.96
Analysts Strong Sell
Price Target $8.00

Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switze...

Industry: Health Information Services
Sector: Healthcare
Phone: 41 21 694 10 60
Address:
La PiEce 12, Rolle, Switzerland
Latest News on SOPH
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting

Jun 22, 2026, 8:25 AM EDT - 12 days ago

SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

Jun 19, 2026, 8:00 AM EDT - 15 days ago

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

Sophia Genetics 10.5M share Spot Secondary priced at $4.75

2026-06-17T02:50:07.000Z - 17 days ago

Sophia Genetics 10.5M share Spot Secondary priced at $4.75

SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares

Jun 16, 2026, 9:21 PM EDT - 17 days ago

SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares

Sophia Genetics $40M Spot Secondary re-offered at $4.75

2026-06-16T21:45:37.000Z - 17 days ago

Sophia Genetics $40M Spot Secondary re-offered at $4.75

Sophia Genetics announces ordinary share offering, no amount given

2026-06-16T20:26:37.000Z - 17 days ago

Sophia Genetics announces ordinary share offering, no amount given

SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

Jun 16, 2026, 4:20 PM EDT - 17 days ago

SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

Sophia Genetics appoints Ross Muken as CEO

2026-06-10T12:10:22.000Z - 24 days ago

Sophia Genetics appoints Ross Muken as CEO

SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting

Jun 10, 2026, 8:00 AM EDT - 24 days ago

SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting

Sophia Genetics management to meet with BTIG

2026-06-09T17:15:26.000Z - 25 days ago

Sophia Genetics management to meet with BTIG

SOPHiA GENETICS Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 3:45 PM EDT - 4 weeks ago

SOPHiA GENETICS Transcript: Jefferies Global Healthcare Conference 2026

Sophia Genetics signs MOU with cancer center for oncology joint venture

2026-06-04T12:23:29.000Z - 4 weeks ago

Sophia Genetics signs MOU with cancer center for oncology joint venture

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

Jun 4, 2026, 8:00 AM EDT - 4 weeks ago

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

Sophia Genetics, Synnovis team on liquid biopsy testing for UK cancer patients

2026-05-13T09:05:09.000Z - 7 weeks ago

Sophia Genetics, Synnovis team on liquid biopsy testing for UK cancer patients

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.

May 13, 2026, 5:00 AM EDT - 7 weeks ago

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.

SOPHiA GENETICS Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS Earnings Call Transcript: Q1 2026

SOPHiA GENETICS Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS Slides: Q1 2026

SOPHiA GENETICS Earnings release: Q1 2026

May 5, 2026, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS Earnings release: Q1 2026

Sophia Genetics reports Q1 EPS (27c), consensus (24c)

2026-05-05T11:05:59.000Z - 2 months ago

Sophia Genetics reports Q1 EPS (27c), consensus (24c)

Sophia Genetics backs FY26 revenue view $92M-$94M, consensus $93.25M

2026-05-05T11:04:33.000Z - 2 months ago

Sophia Genetics backs FY26 revenue view $92M-$94M, consensus $93.25M

SOPHiA GENETICS Reports First Quarter 2026 Results

May 5, 2026, 6:45 AM EDT - 2 months ago

SOPHiA GENETICS Reports First Quarter 2026 Results

SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

Apr 21, 2026, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

Sophia Genetics price target raised to $8 from $7 at BTIG

2026-04-15T10:44:47.000Z - 2 months ago

Sophia Genetics price target raised to $8 from $7 at BTIG

Sophia Genetics management to meet with Craig-Hallum

2026-04-08T15:55:24.000Z - 3 months ago

Sophia Genetics management to meet with Craig-Hallum

Sophia Genetics management to meet with BTIG

2026-04-06T18:45:09.000Z - 3 months ago

Sophia Genetics management to meet with BTIG

Sophia Genetics management to meet with Piper Sandler

2026-03-26T17:35:23.000Z - 3 months ago

Sophia Genetics management to meet with Piper Sandler

Sophia Genetics management to meet with Piper Sandler

2026-03-24T14:40:48.000Z - 3 months ago

Sophia Genetics management to meet with Piper Sandler

SOPHiA GENETICS Transcript: TD Cowen 46th Annual Health Care Conference

Mar 4, 2026, 10:30 AM EST - 4 months ago

SOPHiA GENETICS Transcript: TD Cowen 46th Annual Health Care Conference

Sophia Genetics files to sell 75,000 ordinary shares for holders

2026-03-03T21:26:21.000Z - 4 months ago

Sophia Genetics files to sell 75,000 ordinary shares for holders

Sophia Genetics reports Q4 EPS (28c) vs. (23c) last year

2026-03-03T14:16:02.000Z - 4 months ago

Sophia Genetics reports Q4 EPS (28c) vs. (23c) last year

Sophia Genetics sees FY26 revenue $92M-$94M, consensus $76.47M

2026-03-03T14:15:14.000Z - 4 months ago

Sophia Genetics sees FY26 revenue $92M-$94M, consensus $76.47M

SOPHiA GENETICS Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS Earnings Call Transcript: Q4 2025

SOPHiA GENETICS Earnings release: Q4 2025

Mar 3, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS Earnings release: Q4 2025

SOPHiA GENETICS Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS Annual report: Q4 2025

SOPHiA GENETICS Slides: Q4 2025

Mar 3, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS Slides: Q4 2025

SOPHiA GENETICS Registration statement: Registration Filing

Mar 3, 2026, 7:00 AM EST - 4 months ago

SOPHiA GENETICS Registration statement: Registration Filing

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results

Mar 3, 2026, 6:45 AM EST - 4 months ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

Feb 25, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

Feb 17, 2026, 8:00 AM EST - 4 months ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

Sophia Genetics signs two major U.S. healthcare systems

2026-02-10T14:31:00.000Z - 5 months ago

Sophia Genetics signs two major U.S. healthcare systems

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

Feb 10, 2026, 9:22 AM EST - 5 months ago

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

Sophia Genetics price target raised to $7 from $6 at Guggenheim

2026-01-26T14:41:30.000Z - 5 months ago

Sophia Genetics price target raised to $7 from $6 at Guggenheim

Sophia Genetics sees Q4 revenue ‘at least’ $21M, consensus $20.5M

2026-01-12T12:17:08.000Z - 6 months ago

Sophia Genetics sees Q4 revenue ‘at least’ $21M, consensus $20.5M

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

Jan 12, 2026, 7:00 AM EST - 6 months ago

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

Jan 7, 2026, 8:00 AM EST - 6 months ago

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

Nov 11, 2025, 9:00 AM EST - 8 months ago

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

Nov 11, 2025, 8:01 AM EST - 8 months ago

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

SOPHiA GENETICS Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

SOPHiA GENETICS Earnings Call Transcript: Q3 2025

SOPHiA GENETICS Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

SOPHiA GENETICS Earnings release: Q3 2025

SOPHiA GENETICS Slides: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

SOPHiA GENETICS Slides: Q3 2025

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

Nov 4, 2025, 6:45 AM EST - 8 months ago

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

Oct 21, 2025, 8:00 AM EDT - 9 months ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

Oct 16, 2025, 11:00 AM EDT - 9 months ago

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

Oct 16, 2025, 4:01 AM EDT - 9 months ago

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025, 8:01 AM EDT - 10 months ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025, 8:00 AM EDT - 10 months ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

Sep 22, 2025, 8:00 AM EDT - 10 months ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

AZN

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

Sep 5, 2025, 4:00 AM EDT - 10 months ago

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

SOPHiA GENETICS Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

SOPHiA GENETICS Earnings Call Transcript: Q2 2025

SOPHiA GENETICS Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

SOPHiA GENETICS Earnings release: Q2 2025

SOPHiA GENETICS Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 11 months ago

SOPHiA GENETICS Slides: Q2 2025

SOPHiA GENETICS Registration statement: Registration Filing

Aug 5, 2025, 8:00 AM EDT - 11 months ago

SOPHiA GENETICS Registration statement: Registration Filing

SOPHiA GENETICS Registration statement: Registration Filing

Aug 5, 2025, 8:00 AM EDT - 11 months ago

SOPHiA GENETICS Registration statement: Registration Filing

SOPHiA GENETICS Reports Second Quarter 2025 Results

Aug 5, 2025, 6:45 AM EDT - 11 months ago

SOPHiA GENETICS Reports Second Quarter 2025 Results

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Aug 5, 2025, 6:40 AM EDT - 11 months ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

AZN

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

SOPHiA GENETICS Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 21, 2025, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS Transcript: RBC Capital Markets Global Healthcare Conference 2025

SOPHiA GENETICS Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

SOPHiA GENETICS Earnings Call Transcript: Q1 2025

SOPHiA GENETICS Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

SOPHiA GENETICS Earnings release: Q1 2025

SOPHiA GENETICS Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

SOPHiA GENETICS Slides: Q1 2025

SOPHiA GENETICS Reports First Quarter 2025 Results

May 6, 2025, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS Reports First Quarter 2025 Results

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

Apr 28, 2025, 12:00 PM EDT - 1 year ago

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

AZN

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Apr 22, 2025, 8:00 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

Apr 8, 2025, 2:00 AM EDT - 1 year ago

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

Mar 18, 2025, 9:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

SOPHiA GENETICS Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 5, 2025, 9:10 AM EST - 1 year ago

SOPHiA GENETICS Transcript: TD Cowen 45th Annual Healthcare Conference

SOPHiA GENETICS Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Earnings Call Transcript: Q4 2024

SOPHiA GENETICS Annual report: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Annual report: Q4 2024

SOPHiA GENETICS Earnings release: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Earnings release: Q4 2024

SOPHiA GENETICS Slides: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Slides: Q4 2024

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Mar 4, 2025, 6:45 AM EST - 1 year ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

Feb 24, 2025, 4:00 AM EST - 1 year ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

AZN

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

Feb 18, 2025, 8:30 AM EST - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

Jan 28, 2025, 8:46 AM EST - 1 year ago

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Nov 21, 2024, 5:30 AM EST - 1 year ago

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

SOPHiA GENETICS Transcript: Guggenheim Inaugural Global Healthcare Innovation Conference

Nov 12, 2024, 9:00 AM EST - 1 year ago

SOPHiA GENETICS Transcript: Guggenheim Inaugural Global Healthcare Innovation Conference

SOPHiA GENETICS Earnings Call Transcript: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Earnings Call Transcript: Q3 2024

SOPHiA GENETICS Earnings release: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Earnings release: Q3 2024

SOPHiA GENETICS Slides: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

SOPHiA GENETICS Slides: Q3 2024

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

Nov 5, 2024, 6:32 AM EST - 1 year ago

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

SOPHiA GENETICS Reports Third Quarter 2024 Results

Nov 5, 2024, 6:30 AM EST - 1 year ago

SOPHiA GENETICS Reports Third Quarter 2024 Results

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

Oct 22, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Sep 14, 2024, 9:00 AM EDT - 1 year ago

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

Sep 12, 2024, 7:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

Sep 12, 2024, 4:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

Sep 10, 2024, 10:16 AM EDT - 1 year ago

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

AZN

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Sep 5, 2024, 8:30 AM EDT - 1 year ago

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

SOPHiA GENETICS Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 4, 2024, 1:50 PM EDT - 1 year ago

SOPHiA GENETICS Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

Sep 4, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

Aug 28, 2024, 1:30 PM EDT - 2 years ago

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

SOPHiA DDM™ Platform Certified Under IVDR

Aug 14, 2024, 3:00 AM EDT - 2 years ago

SOPHiA DDM™ Platform Certified Under IVDR